Stephen H. Willard
Director, E-Trade.
Companies
- Longeveron Inc.Chief executive officer Mar 13, 2026 to now1
- NRX Pharmaceuticals, Inc.Board member Jul 22, 2022 to Dec 19, 20222
- NRX Pharmaceuticals, Inc.Chief executive officer Jul 22, 2022 to Dec 19, 20222
- E-TradeBoard member May 26, 2006 to May 13, 20133
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Longeveron Inc. LGVN771,681 shares4$1.2M at $1.50Jul 1, 2026
- NRX Pharmaceuticals, Inc. NRXP50,000 shares5$135.5K at $2.71Dec 16, 2022
As of each latest filing. The line shows shares held over time.
Recent filings
- Jul 1, 2026Shares withheld for tax 18,046 shares at $0.73 of Longeveron Inc.4
- May 1, 2026Granted 500,000 shares of Longeveron Inc.6
- Apr 1, 2026Shares withheld for tax 4,740 shares at $1.12 of Longeveron Inc.7
- Mar 2, 2026Granted 200,000 shares of Longeveron Inc.8
- Mar 2, 2026Shares withheld for tax 105,533 shares at $0.55 of Longeveron Inc.8
- Mar 2, 2026Granted 200,000 shares of Longeveron Inc.8
- Dec 16, 2022Bought 50,000 shares at $1.17 of NRX Pharmaceuticals, Inc.5
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARE-Trade, Board member
- 4
- 5
- 6SEC EDGARForm 4 filed May 5, 2026
- 7SEC EDGARForm 4 filed Apr 3, 2026
- 8SEC EDGARForm 4 filed Mar 13, 2026